Finally, in cancer stem cells (CSCs) of tumorspheres from SW620, the combined treatment of AHCC and ETAS caused a significant reduction in the gene expression of LGR5 and Notch1, opening new perspectives for the testing of these compounds in association with conventional chemotherapy. The gene discussed is LGR5; the disease is cancer.